Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9NQR1
UPID:
KMT5A_HUMAN
Alternative names:
H4-K20-HMTase KMT5A; Histone-lysine N-methyltransferase KMT5A; Lysine N-methyltransferase 5A; Lysine-specific methylase 5A; PR/SET domain-containing protein 07; SET domain-containing protein 8
Alternative UPACC:
Q9NQR1; A8K9D0; Q86W83; Q8TD09
Background:
N-lysine methyltransferase KMT5A, also known as H4-K20-HMTase KMT5A, plays a pivotal role in epigenetic transcriptional repression by specifically monomethylating 'Lys-20' of histone H4 (H4K20me1). This modification is crucial during mitosis, signifying a specific tag for silencing euchromatic genes. KMT5A's activity is not limited to histones; it also monomethylates non-histone proteins, including p53/TP53, thereby repressing p53/TP53-target genes. Its function is essential for cell proliferation, chromosome condensation, and proper cytokinesis.
Therapeutic significance:
Understanding the role of N-lysine methyltransferase KMT5A could open doors to potential therapeutic strategies.